Safely Transition Patients on Chronic Immune Thrombocytopenia Meds at Home

November 2018

The new med fostamatinib (Tavalisse, TAV-ah-lees) will lead to questions about CHRONIC treatment of immune thrombocytopenia (ITP).

We're familiar with treating most patients with acute ITP using high-dose steroids...IVIG...or both.

If thrombocytopenia persists, splenectomy is typically the next step. But newer data support trying chronic ITP meds first.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote